ResMed Inc
(WBO:RMD)
€
195.8
-2.2 (-1.11%)
Market Cap: 28.24 Bil
Enterprise Value: 29.11 Bil
PE Ratio: 31.62
PB Ratio: 6.53
GF Score: 100/100 - Q3 2024 Resmed Inc Earnings Call TranscriptApr 25, 2024€168.2 (-2.52%)Earnings
- Q2 2024 Resmed Inc Earnings Call TranscriptJan 24, 2024€159.75 (-0.47%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q1 2024 Resmed Inc Earnings Call TranscriptOct 26, 2023Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- Resmed Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q4 2023 Resmed Inc Earnings Call TranscriptAug 03, 2023€201.9 (-0.83%)Earnings
- Resmed Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Q3 2023 Resmed Inc Earnings Call TranscriptApr 27, 2023€201.1 (-1.18%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) TranscriptMar 21, 2023
- Resmed Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q2 2023 Resmed Inc Earnings Call TranscriptJan 26, 2023€213.9 (+1.66%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q1 2023 Resmed Inc Earnings Call TranscriptOct 27, 2022€234.05 (+1.47%)Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2022
- Resmed Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q4 2022 Resmed Inc Earnings Call TranscriptAug 11, 2022€238.7 (+2.21%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Resmed Inc to Acquire Medifox Dan GmbH Call TranscriptJun 14, 2022
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 08, 2022
- Resmed Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 01, 2022
- Resmed Inc at Macquarie Australia Conference TranscriptMay 02, 2022
- Q3 2022 Resmed Inc Earnings Call TranscriptApr 28, 2022€199.12 (-3.20%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Resmed Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2022
- Resmed Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Q2 2022 Resmed Inc Earnings Call TranscriptJan 27, 2022€205.2 (-0.34%)Earnings
- Resmed Inc at J.P. Morgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Resmed Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Resmed Inc Annual Shareholders Meeting TranscriptNov 18, 2021
- Resmed Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2021
- Q1 2022 Resmed Inc Earnings Call TranscriptOct 28, 2021€234.5 (+2.13%)Earnings
- Resmed Inc at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Resmed Inc Investor Day TranscriptSep 08, 2021
- Q4 2021 Resmed Inc Earnings Call TranscriptAug 05, 2021€223.7 (-3.66%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Resmed Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Resmed Inc at Macquarie Australia Conference (Virtual) TranscriptMay 04, 2021
- Q3 2021 Resmed Inc Earnings Call TranscriptApr 29, 2021€172.05 (-1.35%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) TranscriptMar 23, 2021
- Q2 2021 Resmed Inc Earnings Call TranscriptJan 28, 2021€180Earnings
- Resmed Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Resmed Inc Annual Shareholders Meeting TranscriptNov 19, 2020
- Resmed Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q1 2021 Resmed Inc Earnings Call TranscriptOct 29, 2020€155Earnings
- Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q4 2020 Resmed Inc Earnings Call TranscriptAug 05, 2020€172Earnings
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 10, 2020
- Resmed Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q3 2020 Resmed Inc Earnings Call TranscriptApr 30, 2020€143 (-2.05%)Earnings
- Q2 2020 Resmed Inc Earnings Call TranscriptJan 30, 2020€150 (-0.66%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Resmed Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q1 2020 Resmed Inc Earnings Call TranscriptOct 24, 2019€116Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 19, 2019
- Resmed Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q4 2019 Resmed Inc Earnings Call TranscriptJul 25, 2019€111.3 (+0.55%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 06, 2019
- Q3 2019 Resmed Inc Earnings Call TranscriptMay 02, 2019€93.93 (+1.15%)Earnings
- Resmed Inc Investor Meeting TranscriptApr 04, 2019
- Q2 2019 Resmed Inc Earnings Call TranscriptJan 24, 2019Earnings
Resmed Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Mar 22, 2022 / 05:30PM GMT
Release Date Price:
€235.3
(+1.12%)
Matthew Ian Mishan
KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
Good afternoon. I'd like to welcome everyone to the first day of the KeyBank Life Sciences MedTech & Investor Forum. My name is Matt Mishan. I'm a senior at MedTech Analyst, and I'm pleased to be joined by ResMed, which is represented today by its CEO, Mick Farrell.
Questions & Answers
Matthew Ian Mishan
KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
For the audience, I'll start us off, but questions can be submitted directly to me by typing into the box below the video screen, and I can relay.
So Mick, welcome. Thank you for joining us. I'm just going to get right to it and ask how should we think about the Russia-Ukraine and the COVID shutdowns in Asia impacting your ability to kind of ramp supply chain at this point?
Michael J. Farrell
ResMed Inc. - CEO & Director
Yes. Well, look, there are a bunch of factors in the market right now,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)